Wilmington, DE, United States of America

Dogwood Pharmaceuticals, Inc.

USPTO Granted Patents = 8

% Expired Patents = 62.5



Forward Citations = 6

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Jayson Michael Rieger (6 out of 39 patents)

silverMedal Robert Douglas Thompson (6 out of 59 patents)

bronzeMedal Anthony Beauglehole (3 out of 10 patents)

4.  Guoquan Wang (3 out of 18 patents)

5.  Frank Schmidtmann (3 out of 5 patents)

6.  Jeffrey William Strovel (2 out of 10 patents)

7.  Janak Khimchand Padia (2 out of 10 patents)

8.  Yi Zang (2 out of 9 patents)

9.  Wieslaw Marek Cholody (2 out of 10 patents)

10.  Karina Zuck (2 out of 3 patents)

11.  Zoe Ohler (2 out of 3 patents)

12.  Gene Ohler (2 out of 2 patents)

13.  Sheela Chellappan (2 out of 3 patents)

14.  Jeffrey W H Watthey (2 out of 3 patents)

15.  Robert D Thompson (0 patent)


8 patents:

Company Overview
Dogwood Pharmaceuticals, Inc. is a leading biopharmaceutical company dedicated to the research, development, and commercialization of innovative therapies for various medical conditions. With a strong focus on improving patient outcomes and quality of life, Dogwood Pharmaceuticals is committed to advancing the field of healthcare through cutting-edge research and development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#389 in Wilmington, DE

#521 in Delaware

#35,941 in US

Wilmington, DE (US)
Wilmington, DE, United States of America
Forward Citations = 6

14 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dogwood Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/dogwood-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…